logo
IHH Healthcare revenue could soften on medical inflation measures

IHH Healthcare revenue could soften on medical inflation measures

Business Times30-05-2025
[SINGAPORE] IHH Healthcare will likely face 'some softening of (patient admissions) and revenue' from measures the group has implemented to combat medical inflation in Malaysia, but the situation has 'improved considerably', said its group chief executive Dr Prem Nair on Friday (May 30).
The group is now negotiating directly with insurers, offering more packages and discounts, he said. Issues that triggered the medical inflation issue, such as a weak ringgit, have 'abated significantly'.
'(Medical inflation) has not fully gone away, but we have all now come to the table,' said Dr Nair, noting that the group is also in discussion with various parties including Malaysia's health ministry and life insurance association to curb medical inflation.
The group in February guided that the country's current sustained period of medical inflation may affect IHH Healthcare's profit margins.
Bank Negara Malaysia cited data indicating that medical cost inflation in Malaysia reached 15 per cent in 2024, above the global and Asia-Pacific average of 10 per cent, and rolled out measures to tackle the high costs.
Dr Nair noted that although Malaysia now faces sustained medical inflation, these issues previously occurred in other markets IHH Healthcare has operations in.
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Sign Up
Sign Up
These countries have since come up with ways to manage high costs. For example, in Singapore, the government formed a committee for payers, providers and regulators to discuss, he said.
'Payer-provider issues have been with us in healthcare for the longest time... and it will never go away because there is a third party paying for the patient,' said Dr Nair.
'I can guarantee it will come up again in another country, and we will have to use the same playbook to manage these issues as well.'
He was speaking at an analyst briefing after the group's first-quarter earnings. IHH Healthcare posted net profit of RM514 million (S$156.3 million) for the three months ended Mar 31, down 33 per cent from RM768 million in the corresponding year-ago period.
Despite the impact of medical inflation and the Ramadan fasting period on Malaysia, contributions from Island Hospital in Penang resulted in the segment's revenue gaining 17 per cent year on year to RM1.1 billion. The segment's earnings before interest, taxes, depreciation and amortisation gained 14 per cent on year to RM273 million.
The group in November last year completed the acquisition of the hospital. This resulted in a 'robust increase in in-patient admissions (in Malaysia), up 6 per cent', said group chief corporate officer Ashok Pandit.
Group chief financial officer Dilip Kadambi added that without the medical tourism-focused Island Hospital, revenue growth in Malaysia would have been 'probably flattish' with a slight increase.
Meanwhile, Singapore's Mount Elizabeth Hospital, which is currently operating at a lower capacity as it undergoes renovations, is on track to fully reopen by Q3 this year, said the group's senior management.
'While Q2 continues to be soft, we anticipate a reasonable rebound in the second half of the year. This recovery will be driven by successful negotiation with payers and completion of Mount Elizabeth Hospital renovations,' said Kadambi.
Maybank Securities analysts Nur Natasha Ariza and Yin Shao Yang said the results are in line with expectations and IHH Healthcare's growth outlook remains intact, as it looks to add around 4,000 beds in several markets by 2028.
'Despite some geopolitical, structural and regulatory challenges across the different countries, we stay bullish on resilient demand and growing case-mix intensity as IHH remains focused on organic and opportunistic inorganic growth,' they said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Asian Markets Rise on Trade Optimism and Strong US Earnings
Asian Markets Rise on Trade Optimism and Strong US Earnings

International Business Times

time2 hours ago

  • International Business Times

Asian Markets Rise on Trade Optimism and Strong US Earnings

Markets across Asia rose on Thursday as optimism from Wall Street and the promise of more U.S. trade deals fueled trading. The MSCI Asia-Pacific index (excluding Japan) climbed 0.4%, to its peak since the year before. Japan's Nikkei 225 continued its surge, moving within a hair's breadth of its all-time high as Singapore's STI and Japan's Topix both breached heights. x Recent trade agreements with Japan, Indonesia, and the Philippines have lifted investor confidence. Now it is talking with the EU, raising the possibility of a bigger deal. European stock futures were swept along with the optimism: Euro Stoxx 50 futures rose 1.17%, DAX futures 1.15%, and FTSE futures 0.39%. "Markets seem to be ready to throw caution aside on the back of significant trade deals," said NAB strategist Gavin Friend. Trump's Fed Visit Sparks New Speculation In a surprise, President Trump is scheduled to visit the Federal Reserve on Thursday, two days before the next policy meeting. Analysts speculated that the visit might be intended to pressure Federal Reserve Chair Jerome Powell to lower interest rates. The Fed is overwhelmingly anticipated to keep rates unchanged next week. The 10-year U.S. Treasury yield was unchanged at 4.3937%, while the 2-year yield traded at 3.8908%. The dollar fell 0.31% against the yen to 146.03 and dipped briefly on the dollar index, down to 97.156. Earnings and Wall Street Drive Momentum U.S. stocks rose strongly on Wednesday. The Dow rose 1.1%, the S&P 500 climbed 0.76%, and the Nasdaq gained 0.6%. To date, 23% of S&P 500 companies have reported results for the second quarter, with 85% of them beating expectations, according to LSEG data. In Asia, shares of the South Korean microchip maker SK Hynix and the Indian technology services company Infosys both provided optimistic earnings forecasts, setting aside concerns about tariffs. The focus of investors now turns to reports from big U.S. companies and the ECB's rate decision later on Thursday. The ECB is expected to pause after seven straight cuts. Traders anticipate one more cut by December. Trump's earlier threat of a 30% tariff on EU goods could potentially be softened down, as officials indicate that a compromise of a 15% flat rate is in the works. Commodities Steady Ahead of Central Bank Moves Oil prices rose on Thursday following a sharp drop in the United States' crude stocks and amid expectations of potential trade deals lifting demand for crude. American crude gained 0.52% to $65.59 a barrel. Spot gold eased marginally to $3,382.79 an ounce as safe-haven demand waned.

Singapore recalls Australian salami product after salmonella detected
Singapore recalls Australian salami product after salmonella detected

CNA

time4 hours ago

  • CNA

Singapore recalls Australian salami product after salmonella detected

SINGAPORE: The Singapore Food Agency (SFA) said on Thursday (Jul 24) it has ordered a recall of Primo Reserve Hot Sopressa Salami after salmonella was detected in it. Salmonella is a pathogenic bacterium that can cause food poisoning. Symptoms may include diarrhoea, abdominal pain, fever, nausea and vomiting. SFA said it has directed the importer, Alternative Selection, to recall the Australian product. "Consumers who have purchased the implicated product are advised not to consume it," said SFA. "Those who have consumed the implicated product and have concerns about their health should seek medical advice. Consumers may contact their point of purchase for enquiries," it added.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store